Related references
Note: Only part of the references are listed.Design, synthesis and applications of hyaluronic acid-paclitaxel bioconjugates
Francesca Leonelli et al.
MOLECULES (2008)
Investigating the mechanism of enhanced cytotoxicity of HPMA copolymer-Dox-AGM in breast cancer cells
Francesca Greco et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Biological and clinical characterization of paclitaxel poliglumex (PPX, CT-2103), a macromolecular polymer-drug conjugate
Stewart D. Chipman et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2006)
Polymer conjugates as anticancer nanomedicines
Ruth Duncan
NATURE REVIEWS CANCER (2006)
Paclitaxel poliglumex (XYOTAX™, CT-2103):: A macromolecular taxane
JW Singer
JOURNAL OF CONTROLLED RELEASE (2005)
Poly(ethylene glycol)-poly(ester-carbonate) block copolymers carrying PEG-peptidyl-doxorubicin pendant side chains: Synthesis and evaluation as anticancer conjugates
L Andersson et al.
BIOMACROMOLECULES (2005)
Polymeric anticancer drugs with pH-controlled activation
K Ulbrich et al.
ADVANCED DRUG DELIVERY REVIEWS (2004)
Polymeric anticancer drugs with pH-controlled activation
K Ulbrich et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2004)
Protein, peptide and non-peptide drug PEGylation for therapeutic application
G Pasut et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2004)
PEG drugs: an overview
RB Greenwald
JOURNAL OF CONTROLLED RELEASE (2001)
Share Paper
